These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 36070946)
1. Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination. Ohmura SI; Ohkubo Y; Ishihara R; Otsuki Y; Miyamoto T Intern Med; 2022 Nov; 61(22):3453-3457. PubMed ID: 36070946 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccination-related small vessel vasculitis with multiorgan involvement. Kim Y; Kang J; Lee SG; Kim GT Z Rheumatol; 2022 Aug; 81(6):509-512. PubMed ID: 35587834 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related]
4. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021. Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735 [TBL] [Abstract][Full Text] [Related]
5. A broad assessment of covid-19 vaccine safety using tree-based data-mining in the vaccine safety datalink. Yih WK; Daley MF; Duffy J; Fireman B; McClure D; Nelson J; Qian L; Smith N; Vazquez-Benitez G; Weintraub E; Williams JTB; Xu S; Maro JC Vaccine; 2023 Jan; 41(3):826-835. PubMed ID: 36535825 [TBL] [Abstract][Full Text] [Related]
6. Tree-based data mining for safety assessment of first COVID-19 booster doses in the Vaccine Safety Datalink. Katherine Yih W; Daley MF; Duffy J; Fireman B; McClure D; Nelson J; Qian L; Smith N; Vazquez-Benitez G; Weintraub E; Williams JTB; Xu S; Maro JC Vaccine; 2023 Jan; 41(2):460-466. PubMed ID: 36481108 [TBL] [Abstract][Full Text] [Related]
7. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US. Hause AM; Zhang B; Yue X; Marquez P; Myers TR; Parker C; Gee J; Su J; Shimabukuro TT; Shay DK JAMA Netw Open; 2022 Jul; 5(7):e2222241. PubMed ID: 35838667 [TBL] [Abstract][Full Text] [Related]
8. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination. Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611 [TBL] [Abstract][Full Text] [Related]
9. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022. Hause AM; Marquez P; Zhang B; Myers TR; Gee J; Su JR; Blanc PG; Thomas A; Thompson D; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(44):1401-1406. PubMed ID: 36327162 [TBL] [Abstract][Full Text] [Related]
10. Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Takeyama R; Fukuda K; Kouzaki Y; Koga T; Hayashi S; Ohtani H; Inoue T Acta Neurochir (Wien); 2022 Feb; 164(2):543-547. PubMed ID: 34783899 [TBL] [Abstract][Full Text] [Related]
11. From trial to practice: incidence and severity of COVID-19 vaccine side effects in a medically at-risk and vaccine-hesitant community. Joyce MC; Mountjoy NJ; Johnson JA; Newman JT; Bandy DL; Atalla NA; Singh A; McElroy D BMC Public Health; 2022 Dec; 22(1):2351. PubMed ID: 36517842 [TBL] [Abstract][Full Text] [Related]
12. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021. Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835 [TBL] [Abstract][Full Text] [Related]
14. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease. Beckley M; Olson AK; Portman MA JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521 [TBL] [Abstract][Full Text] [Related]